These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17707019

  • 1. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
    Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA.
    J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
    [Abstract] [Full Text] [Related]

  • 2. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME, Husmann DA, Rathbun SR, Weight CJ, Kramer SA.
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
    Yu RN, Roth DR.
    Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
    [Abstract] [Full Text] [Related]

  • 6. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.
    Lee EK, Gatti JM, Demarco RT, Murphy JP.
    J Urol; 2009 Apr; 181(4):1869-74; discussion 1874-5. PubMed ID: 19233403
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Yucel S, Gupta A, Snodgrass W.
    J Urol; 2007 Apr; 177(4):1505-9. PubMed ID: 17382765
    [Abstract] [Full Text] [Related]

  • 8. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R, Vandersteen D.
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P, Kutasy B, Colhoun E, Hunziker M.
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
    Moore K, Bolduc S.
    J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
    Palmer LS.
    J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
    [Abstract] [Full Text] [Related]

  • 15. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH, Madden-Fuentes RJ, Lindsay NE, Roth DR.
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
    Traxel E, DeFoor W, Reddy P, Sheldon C, Minevich E.
    J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
    Puri P, Mohanan N, Menezes M, Colhoun E.
    J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.